Comments to FDA: OTC Monograph Reform and User Fees Share page: Docket Number: FDA-2016-N-1092 While the monograph system has served our nation well, it has become cumbersome and outdated and needs to be modernized. Download Document Issues: OTC Medicines Monograph Reform User Fees Related Posts Press Releases and Statements CHPA Applauds Bipartisan Bill to Streamline Access to Next-Generation Sunscreens in the U.S. Jun 4, 2025 Comments Comments Regarding Amending OTC Monograph M012: Cold, Cough, Allergy, Bronchodilator, and Antiasthmatic Drug Products for Human Use May 7, 2025 Letter Letter Regarding Office of Management & Budget Request for Information: Deregulation May 12, 2025